AI assistant
Newton Resources Ltd — Board/Management Information 2015
Aug 10, 2015
49785_rns_2015-08-10_64d8c775-0deb-45a9-a492-77c5b19db61c.pdf
Board/Management Information
Open in viewerOpens in your device viewer
Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.
==> picture [365 x 87] intentionally omitted <==
(Incorporated in the Cayman Islands with limited liability) (Stock Code: 1231)
APPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTOR AND MEMBER OF BOARD COMMITTEES
The board (“ Board ”) of directors (“ Directors ”) of Newton Resources Ltd (the “ Company ” and together with its subsidiaries, the “ Group ”) is pleased to announce that Mr. Shin Yick, Fabian (“ Mr. Shin ”) has been appointed as an independent non-executive Director and a member of each of audit committee (“ Audit Committee ”), remuneration committee (“ Remuneration Committee ”) and nomination committee of the Company with effect from 14 August 2015.
Mr. Shin, aged 46, is currently the chief executive officer of Zhaobangji International Capital Limited which is engaged in investment business and an independent nonexecutive director of Lisi Group (Holdings) Limited (stock code: 526), a company listed on the main board of the Stock Exchange of Hong Kong Limited (the “ Stock Exchange ”). He was the deputy chief executive officer of CMB International Capital Limited from February 2010 to July 2015. Mr. Shin has over 24 years of experience in investment banking and financial management. Prior to joining CMB International Capital Limited, he worked in several investment banks in Hong Kong.
Mr. Shin was an independent non-executive director of Little Sheep Group Limited (stock code: 968), a company listed on the main board of the Stock Exchange, and delisted from the main board of the Stock Exchange in February 2012 and C&O Pharmaceutical Technology (Holdings) Limited, (stock code: E92), a company listed on the main board of Singapore Exchange Securities Trading Limited (the “ SGX-ST ”), and delisted from the main board of the SGX-ST in December 2011, up to his resignation in February 2012 and December 2011 respectively.
Mr. Shin graduated from the University of Birmingham in England with a bachelor’s degree in commerce. After graduation, he worked in the audit department of Deloitte Touche Tohmatsu. He had also worked in a listed company in Hong Kong as group financial controller. He is a fellow member of Hong Kong Institute of Certified Public Accountants, Association of Chartered Certified Accountants, The Institute of Chartered Secretaries and Administrators and The Hong Kong Institute of Chartered Secretaries.
1
Save as disclosed above, in the three years preceding the date of his appointment, Mr. Shin did not hold any position with the Company or other members of the Group or any directorship in other listed public companies or have any other major appointments.
Mr. Shin entered into a letter of appointment with the Company on 10 August 2015 for a fixed term of three years commencing from 14 August 2015, subject to retirement by rotation and re-election at annual general meetings pursuant to the articles of association of the Company. In respect of his service to the Company as an independent nonexecutive Director, Mr. Shin is entitled to a Director’s fee of HK$220,500 per annum. Save for the Director’s fee, he is not expected to receive any other remuneration for holding his office as an independent non-executive Director. Mr. Shin’s annual emoluments as independent non-executive Director was determined by the Board based on the recommendation from the Remuneration Committee with reference to the Company’s performance, his duties and responsibilities with the Company, and prevailing market conditions. The director’s remuneration of Mr. Shin will be subject to annual review by the Remuneration Committee and the Board.
As at the date of this announcement, Mr. Shin does not have any interests in shares of the Company within the meaning of Part XV of the Securities and Futures Ordinance (Chapter 571 of the Laws of Hong Kong). Save as disclosed above, Mr. Shin does not have any relationship with any other Directors, senior management, substantial shareholders or controlling shareholders of the Company.
Mr. Shin has not been involved in any of the matters as mentioned under Rules 13.51(2)(h) to 13.51(2)(v) of the Rules Governing the Listing of Securities on The Stock Exchange (“ Listing Rules ”) and there are no other matters in relation to Mr. Shin’s appointment that need to be brought to the attention of the shareholders of the Company.
Upon the appointment of Mr. Shin as an independent non-executive Director and a member of the Audit Committee becoming effective, the Company will be in compliance with the requirements of Rules 3.10(1), 3.10A and 3.21 of the Listing Rules.
The Board would like to express its warmest welcome to Mr. Shin for joining the Board.
By Order of the Board Newton Resources Ltd Cheng Kar Shun Chairman and Non-executive Director
Hong Kong, 10 August 2015
As at the date of this announcement, the executive Directors are Mr. Li Changfa and Mr. Luk Yue Kan; the non-executive Directors are Dr. Cheng Kar Shun, Mr. Lam Wai Hon, Patrick, Mr. Cheng Chi Ming, Brian and Mr. Wu Wai Leung, Danny; and the independent nonexecutive Directors are Mr. Tsui King Fai and Mr. Lee Kwan Hung.
2